Position in ZTS
as of Mar 31, 2026
· filed Apr 13, 2026
Position Value
$1,096,161
-$57,230 QoQ
Shares Held
9,273
+1.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026IFP Advisors, Inc holds $7,125,146 across 42 Drug Manufacturers - Specialty & Generic names. ZTS ranks #2 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
142,344 | $4,287,401 | |
| 2 | ZTS |
Zoetis Inc.
This page
|
9,273 | $1,096,161 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,545 | $916,154 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
2,792 | $367,818 | |
| 5 | CTOR |
Citius Oncology, Inc.
|
107,424 | $66,602 | |
| 6 | ALKS |
Alkermes plc.
|
1,398 | $49,433 | |
| 7 | HLN |
Haleon plc
|
4,745 | $47,497 | |
| 8 | TLRY |
Tilray Brands, Inc.
|
5,513 | $35,669 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,096,161 | 9,273 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $1,153,391 | 9,167 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,402,330 | 9,584 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $1,539,850 | 9,874 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $1,637,608 | 9,946 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,634,676 | 10,033 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $1,733,997 | 8,875 | Shares | Sole | 2025-02-04 | |
| 2024-06-30 | $1,581,736 | 9,124 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,329,652 | 7,858 | Shares | Sole | 2024-07-30 | |
| 2023-12-31 | $1,515,209 | 7,677 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $1,304,502 | 7,498 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $3,464,348 | 20,117 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,234,675 | 37,459 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $6,044,894 | 41,248 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $5,243,979 | 35,363 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $5,681,480 | 33,053 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $6,233,465 | 33,053 | Shares | Sole | 2022-09-06 | |
| 2021-12-31 | $6,904,584 | 28,294 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $5,530,660 | 28,488 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $5,183,603 | 27,815 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $4,255,739 | 27,024 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $3,699,587 | 22,354 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $3,379,997 | 20,439 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $2,724,081 | 19,878 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $2,005,908 | 17,044 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||